Boston Scientific Sustains Momentum in the PFA Market: What's Next?

BSX builds momentum in PFA as FARAPULSE posts strong growth, and new trial results and expanded FDA labeling boost its AF treatment push.

Zacks Investment Research • Dec 11, 2025

Boston Scientific (BSX) Stock Falls Amid Market Uptick: What Investors Need to Know

The latest trading day saw Boston Scientific (BSX) settling at $91.75, representing a -1.02% change from its previous close.

Zacks Investment Research • Dec 12, 2025

PAHC vs. BSX: Which Stock Is the Better Value Option?

Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks presents investors with the better value opportunity right now?

Zacks Investment Research • Dec 8, 2025

M&A Strategy Strengthens Boston Scientific's Growth Prospects

BSX accelerates growth as a wave of acquisitions boosts core portfolios and fuels expansion into high-growth adjacent markets.

Zacks Investment Research • Dec 2, 2025

Boston Scientific Corporation (BSX) Presents at Citi Annual Global Healthcare Conference 2025 Prepared Remarks Transcript

Boston Scientific Corporation (BSX) Presents at Citi Annual Global Healthcare Conference 2025 Prepared Remarks Transcript

Seeking Alpha • Dec 2, 2025

Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Zacks Investment Research • Nov 28, 2025

Why Boston Scientific (BSX) is a Top Momentum Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Investment Research • Nov 28, 2025

Boston Scientific's Margins Strengthen in Q3: What's Driving It?

BSX posts stronger Q3 margins as growth in EP and WATCHMAN lifts product mix despite tariff pressure.

Zacks Investment Research • Nov 25, 2025

Why Boston Scientific (BSX) is a Top Growth Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Investment Research • Nov 25, 2025

BSX vs. EW: Which Heart Device Stock Is the Smarter Investment Now?

Boston Scientific's EP breadth, WATCHMAN momentum and acquisitions give it an edge over Edwards in cardiovascular devices.

Zacks Investment Research • Nov 24, 2025